William Garvin, Shareholder in the firm's FDA & Biotechnology practice, comments on the FDA's "digital health innovation plan," which includes wellness and health trackers and software, in "FDA Plans to Clarify Digital Health Regulations" in Bloomberg BNA's Health Care Blog.